4/A//SEC Filing
Avgerinos George 4/A
Accession 0001144204-19-034107
CIK 0001429260other
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 4:01 PM ET
Size
7.6 KB
Accession
0001144204-19-034107
Insider Transaction Report
Form 4/AAmended
Avgerinos George
SVP, Biologics Operations
Transactions
- Award
COMMON STOCK, PAR VALUE $0.001
2018-12-11+400,000→ 655,170 total - Award
Options to purchase Common Stock
2019-04-17+200,000→ 200,000 totalExercise: $9.21Exp: 2023-06-04→ Common Stock (200,000 underlying)
Footnotes (2)
- [F1]400,000 shares of the Issuer's common stock owned by the Reporting Person vested on December 11, 2018, triggering the sale of 97,325 shares of the Issuer's common stock as reported on the Form 4, filed on December 13, 2018 (the "Original Form 4"). The 400,000 shares of the Issuer's common stock were inadvertently omitted from the Original Form 4.
- [F2]The options granted were fully vested on June 4, 2016. This grant was reinstated by the Issuer's Board of Directors on April 17, 2019.
Documents
Issuer
Fortress Biotech, Inc.
CIK 0001429260
Entity typeother
Related Parties
1- filerCIK 0001578699
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 4:01 PM ET
- Size
- 7.6 KB